Filing Details
- Accession Number:
- 0000899243-16-034863
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-02 18:00:29
- Reporting Period:
- 2016-12-01
- Filing Date:
- 2016-12-02
- Accepted Time:
- 2016-12-02 18:00:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238483 | Jr P Samuel Sears | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2016-12-01 | 12,000 | $1.67 | 64,863 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares of Issuer's Common Stock were sold pursuant to a pre-planned 10b5-1 plan to cover the Reporting Person's tax liability upon the vesting of RSUs in August 2016.
- On December 1, 2016, the Reporting Person sold an aggregate of 12,000 shares of the Issuer's Common Stock at a weighted average price of $1.67 per share. The highest sale price for the Common Stock was $1.75 per share and the lowest sale price was $1.60 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Form 4 filed on August 12, 2016 inadvertently excluded 1,000 shares held by the Reporting Person.
Billionaire Hedge Funds
